These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9145710)

  • 1. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Lapane KL; Hume AL
    JAMA; 1997 May; 277(18):1435; author reply 1436-7. PubMed ID: 9145710
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Rumboldt Z; Bozic I; Rakic D
    JAMA; 1997 May; 277(18):1435-6; author reply 1436-7. PubMed ID: 9145711
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Gambassi G; Bernabei R; Carbonin P
    JAMA; 1997 May; 277(18):1433-4; author reply 1436-7. PubMed ID: 9145707
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Holt RJ
    JAMA; 1997 May; 277(18):1434; author reply 1436-7. PubMed ID: 9145708
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Hein HA
    JAMA; 1997 May; 277(18):1436; author reply 1436-7. PubMed ID: 9145712
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Levinson D
    JAMA; 1997 May; 277(18):1436; author reply 1436-7. PubMed ID: 9145713
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse outcomes of underuse of beta-blockers in elderly patients.
    Jay SJ
    JAMA; 1997 May; 277(18):1434-5; author reply 1436-7. PubMed ID: 9145709
    [No Abstract]   [Full Text] [Related]  

  • 8. Review: Beta-blockers increase fatigue and sexual dysfunction but not depression after myocardial infarction.
    Ko DT; Hebert PR; Krumholz HM
    ACP J Club; 2003; 138(1):30; author reply 30. PubMed ID: 12511138
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy: Current role of β-blockers after MI in patients without HF.
    Mukherjee D; Eagle KA
    Nat Rev Cardiol; 2016 Dec; 13(12):699-700. PubMed ID: 27786237
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
    Soumerai SB; McLaughlin TJ; Spiegelman D; Hertzmark E; Thibault G; Goldman L
    JAMA; 1997 Jan; 277(2):115-21. PubMed ID: 8990335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of beta-blockers following myocardial infarction.
    Budnitz D; Neuman WR
    JAMA; 2001 Feb; 285(8):1013. PubMed ID: 11209161
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.
    Ko DT; Hebert PR; Coffey CS; Sedrakyan A; Curtis JP; Krumholz HM
    JAMA; 2002 Jul; 288(3):351-7. PubMed ID: 12117400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery disease. Are β-blockers truly helpful in patients with CAD?
    Danchin N; Laurent S
    Nat Rev Cardiol; 2013 Jan; 10(1):11-2. PubMed ID: 23149827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression after myocardial infarction: unraveling the mystery of poor cardiovascular prognosis and role of beta-blocker therapy.
    von Känel R; Begré S
    J Am Coll Cardiol; 2006 Dec; 48(11):2215-7. PubMed ID: 17161248
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease.
    Jansen RW; Gurwitz JH
    Drugs Aging; 1994 Mar; 4(3):175-83. PubMed ID: 7911042
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing beta-blocker use after myocardial infarction.
    Howard PA; Ellerbeck EF
    Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess.
    Di Bari M; Marchionni N; Pahor M
    Drugs Aging; 2003; 20(1):13-22. PubMed ID: 12513113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.
    Avezum A; Pais P; Flather MD; Anand S; Yusuf S
    Indian Heart J; 1995; 47(2):95-105. PubMed ID: 7590849
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.
    McCormick D; Gurwitz JH; Savageau J; Yarzebski J; Gore JM; Goldberg RJ
    J Gen Intern Med; 1999 Feb; 14(2):73-81. PubMed ID: 10051777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies highlight low use of beta-blockers.
    Am J Health Syst Pharm; 1998 Oct; 55(19):1967. PubMed ID: 9784780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.